2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Agranulocytosis: new trials by email Literature Review of Agranulocytosis trials Research Report on Agranulocytosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2) - Prevention of Chemotherapy-induced Myelosuppression | Phase 1 | Terminated | Aileron Therapeutics, Inc. | 6 | 2023-01-09 | 2023-02-27 |
| Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma epoetin alfa, filgrastim, recombinant flt3 ligand - Lymphoma, Neutropenia | Phase 1 | Terminated | Northwestern University | 3 | 1999-09-01 | 2012-06-01 |
Neutropenia (2) · Alopecia (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukocyte Disorders (2) · Leukopenia (2) · Neoplasms (2) · Pathological Conditions, Signs and Symptoms (2) · Breast Diseases (1) · Chronic Disease (1) · DNA Virus Infections (1) · Disease Attributes (1) · Epstein-Barr Virus Infections (1) · Hair Diseases (1) · Herpesviridae Infections (1)
Cyclophosphamide (1) · Docetaxel (1) · Doxorubicin (1) · Epoetin Alfa (1) · Filgrastim (1) · Stem Cell Factor (1) · flt3 ligand protein (1) · sargramostim (1)
Aileron Therapeutics, Inc. (1) · Northwestern University (1)
United States (2) · Bosnia and Herzegovina (1) · Bulgaria (1) · Serbia (1)